CTLA-4 acts as an inhibitor of autoimmunity, and the defects in the B7-CD28/CTLA-4 pathway may lower the threshold of autoreactive lymphocyte activation and which in turn may lead to the development of an autoimmune disease [25]. This evidence concerns the gene CTLA4 and autoimmune disease.